OAM
IONS icon

Orinda Asset Management’s Ionis Pharmaceuticals IONS Stock Holding History

Orinda Asset Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-2,620
Closed -$102K – 132
2014
Q3 		$102K Hold
2,620
– – 0.17% 92
2014
Q2 		$90K Sell
2,620
-1,338
-34% -$42.1K 0.17% 97
2014
Q1 		$171K Sell
3,958
-4,034
-50% -$196K 0.37% 68
2013
Q4 		$318K Sell
7,992
-6,673
-46% -$238K 0.71% 34
2013
Q3 		$551K Sell
14,665
-1,116
-7% -$33.3K 1.73% 12
2013
Q2 		$424K Buy
+15,781
New +$336K 1.39% 22

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Orinda Asset Management's IONS Position: Q4 2014 in Review

Orinda Asset Management sold out of Ionis Pharmaceuticals (IONS) in Q4 2014, closing a stake of 2,620 shares — an estimated $102K sold.

Orinda Asset Management first reported a position in IONS in Q2 2013 and held it in 6 quarters. The position peaked at $551K in Q3 2013. 285 funds tracked by Wall St. Rank hold IONS as of Q4 2014.

  • Orinda Asset Management reported no remaining Ionis Pharmaceuticals position as of Q4 2014 after selling out during the quarter.
  • Orinda Asset Management sold 2,620 Ionis Pharmaceuticals shares in Q4 2014, an estimated $102K.
  • Orinda Asset Management first reported a position in Ionis Pharmaceuticals in Q2 2013 and held it in 6 quarters.
  • Orinda Asset Management's Ionis Pharmaceuticals position peaked at $551K in Q3 2013.
  • 285 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2014.

Based on Orinda Asset Management's 13F filing for Q4 2014, filed 2 Feb 2015.